Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

No-Receipt date 2022-04017 - 22/11/2022
No-Filing date 20220402302 - 22/11/2022
No-Granting date 3111547 - 28/11/2022
No-EPO application date 14707647.5 - 18/02/2014
No-EPO granting date 2958945 - 19/10/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 11/2022 - 12/12/2022
Expiration date 19/02/2034
Kind of title Validation of European Patent
Legal status VALID
Priorities WOPCT/EP2013/00050520/02/2013/WO
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 39/00
C07K 16/30

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1466626 ASTELLAS PHARMA INC. 5-1, NIHONBASHI-HONCHO 2-CHOMECHUO-KU TOKYO 103-8411 JAPAN
1466627 TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG- UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH FREILIGRATHSTRASSE 1255131 MAINZ GERMANY

Inventors
CodeFirstnameSurname
3792088 SAHIN,UGUR
3792089 TURECI, OZLEM
3792090 MITNACHT-KRAUS, RITA
3792091 WOLL, STEFAN
3792092 JACOBS, STEFAN
3792093 HEINZ, CORNELIA

Representatives
CodeFirstnameSurnameAddressTownZip
3098ANNAGIAKOUMIALKAMENOUS 12-14ATHINA (ATTIKIS)10439

Contact
CodeFirstnameSurnameAddressTownZipCountry
8397ANDRONIKIMISIOUANALIPSEOS 23 KAI MARATHONOS 27VRILISSIA (ATTIKIS)15235 GREECE

Owners History

Title Instruments

Payments history 12 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015